The Future of Abortion is Now: Mifepristone by Mail and In-Clinic Abortion Access in the United States.
Sign Up to like & getrecommendations! Published in 2021 at "Contraception"
DOI: 10.1016/j.contraception.2021.03.033
Abstract: The COVID-19 pandemic disrupted health care delivery in all aspects of medicine, including abortion care. For six months, the mifepristone Risk Evaluation and Mitigation strategy (REMS) was temporarily blocked, allowing for remote provision of medication… read more here.
Keywords: abortion; medication abortion; future abortion; care ... See more keywords